期刊文献+

表面响应曲面法优化牛磺罗定衍生化条件的研究 被引量:1

Response surface methodology optimizing derivatization condition of taurolidine
原文传递
导出
摘要 目的:在单因素实验的基础上,利用表面响应曲面法(RSM)对HPLC-UV法测定牛磺罗定含量中的牛磺罗定衍生化条件进行优化。方法:以衍生化试剂不同的浓度、反应时间和反应温度为因子,以反应后衍生化产物的量(用峰面积表示)为响应因子,对衍生化条件进行优化。结果:最佳衍生化条件是反应温度为100℃,衍生化试剂浓度为20 g.L-1,反应时间为88 min。结论:本方法结果准确可靠,可应用于牛磺罗定的衍生化。 Objective:On the base of the single factor investigation,response surface mathodology was applied to optimize the derivatization condition of taurolidine.Methods:Different derivatization reagent concentrations,reaction time and reaction temperature were taken as factor.The amount of the derivative products(expressed by peak area)was taken as response factor.Results:The optimizing derivatization condition of taurolidine was as follows:the reaction temperature(100 ℃),the derivatization reagent concentration(20 g·L-1),the reaction time(88 min).Conclusion:The method is accurate,reliable and can be applied to derivatize taurodiline.
出处 《药物分析杂志》 CAS CSCD 北大核心 2011年第3期479-483,共5页 Chinese Journal of Pharmaceutical Analysis
关键词 曲面法 牛磺罗定 对甲基苯磺酰氯 衍生化 response surface methodology taurolidine p-toluenesulfonyl chloride derivatization
  • 相关文献

参考文献8

  • 1McCartney AC, Browne MK. Clinical studies on administration of taurolidine in severe sepsis: a preliminary study. Prog Clin Biol Res, 1988,272:361.
  • 2Bieselt R. Surgical therapy of pleural empyema with tauroline[ in German ]. Langenbecks Arch Chir, 1997,382 (4 Suppl. 1 ) : S42.
  • 3Leaper DJ. Prevention af peritoneal adhesions after thermalinjury using noxythiolin and taurolin. In: Bruckner WL, Pfirrmann RW, editors. A new concept in antimicrobial chem - otherapy for surgical infection.Baltimore : Urban Schwarzenberg, 1985.115.
  • 4Kaptanoglu L,Kucuk H F, Colak E,et al. The effect of taurolidine on experimental thrombus formation.. Eur J Pharmaeol,2008,578 (2 - 3 ) :238.
  • 5Catabresi P, Goulette FA, Darnowski JW. Taurolidine: cytotoxic and mechanistic evaluation of a novel anti -neoplastic agent. Cancer Res, 2001,61 ( 18 ) :6816.
  • 6Stendel R, Stoltenburg - Didinger G, Brock M. The aminosulphonic acid derivative taurolidine induces apoptotic changes inbrain tumour cells. 12th World Congress Neurosurgery ,2001, Sydney, 128.
  • 7Stendel R, Scheurer L, Schlatterer K, et al. Pharmacokinetics of tauro- lidine following repeated intravenous infusions measured by HPLCESI - MS/MS of the derivatives taumltame and taurinamide in glioblastoma patients. Clin Pharmacokinet, 2007,46 ( 6 ) : 513.
  • 8Woolfson AD,Gorman SP, McCafferty DF, et al. Assay procedures for taurolidine solutions using preeolumn dramatizations and high - performance liquid chromatography with uorescence detection. Int J Pharm,1989( 49 ) :135.

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部